Differential release kinetics of cardiac biomarkers in off-pump coronary bypass

Abstract

Background

Differential release kinetics of the cardiac biomarkers (B-type natriuretic peptide, troponin I, and creatine kinase-MB) following off-pump coronary artery bypass are not well characterized.

Methods

Biomarker levels were assessed at 6, 24, 48 h, and 1 month preoperatively, in 80 patients who underwent off-pump coronary artery bypass.

Results

All biomarkers increased within 6 h of surgery. Peak B-type natriuretic peptide levels occurred at 24–48 h in 96% of patients, but only two-thirds had peak troponin I and creatine kinase-MB levels at this time, reflecting different release patterns. Levels of all biomarkers declined within 48 h, but 42% of patients still had B-type natriuretic peptide >100 pg·mL⁻¹ at 1 month. Those with baseline B-type natriuretic peptide > 100 pg·mL⁻¹ had a lower left ventricular ejection fraction (43.6% vs. 55.6%, p < 0.01) and longer inotropic (43.8 vs. 31.4 h, p = 0.03) and ventilator support (34 vs. 25.5 h, p = 0.04) than those with lower levels. B-type natriuretic peptide levels correlated positively with angiographic Syntax score (p = 0.02) and negatively with left ventricular ejection fraction (p < 0.001). Only baseline B-type natriuretic peptide predicted the durations of inotropic support (p = 0.01) and ventilation (p = 0.02). Postoperative B-type natriuretic peptide at 6, 24, and 48 h and delta B-type natriuretic peptide were significant predictors of mean ventilation time.

Conclusion

Even in patients undergoing off-pump surgery, there is significant natriuretic peptide and myocardial enzyme release. Only B-type natriuretic peptide levels had an association with postoperative variables.

Keywords

Biological markers coronary artery bypass off-pump natriuretic peptide brain prognosis troponin I

Get full access to this article

View all access options for this article.

References

Maisel

Krishnaswamy

Nowak

. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161–167.

Suzuki

Yoshimura

Nakayama

. Plasma level of B-type natriuretic peptide a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 2004; 110: 1387–1391.

Bibbins-Domingo

Ansari

Schiller

Massie

Whooley

. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2003; 108: 2987–2992.

Berendes

Schmidt

Van Aken

. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 2004; 98: 11–19.

Provenchère

Berroeta

Reynaud

. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34: 995–1000.

Hutfless

Kazanegra

Madani

. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43: 1873–1879.

Fox

Muehlschlegel

Body

. Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology 2010; 112: 842–851.

Avidan

Meehan

Ponte

El-Gamel

Sherwood

. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta 2001; 303: 127–132.

Shroyer

Grover

Hattler

. On-pump versus off-pump coronary artery bypass surgery. N Engl J Med 2009; 361: 1827–1837.

10.

Lamy

Devereaux

Prabhakaran

. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med 2012; 366: 1489–1497.

11.

Litton

. The use of pre-operative brain natriuretic peptides as a predictor of adverse outcomes after cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2012; 41: 525–534.

12.

Pande

Agarwal

Kundu

Kale

Chaudhary

Dhir

. Off-pump coronary artery bypass in severe left ventricular dysfunction. Asian Cardiovasc Thorac Ann 2009; 17: 54–58.

13.

Morimoto

Mori

Ishiguro

Matsuda

Hara

Kuroda

. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today 1998; 28: 23–29.

14.

Guerin

Ayed

Varnous

. Release of brain natriuretic-related peptides (BNP, NT-proBNP) and cardiac troponins (cTnT, cTnI) in on-pump and off-pump coronary artery bypass surgery. Surg Today 2006; 36: 783–789.

15.

Kerbaul

Collart

Giorgi

. Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Intensive Care Med 2004; 30: 1799–1806.

16.

Tziomalos T, Sevastidou J, Pitsis AA, et al. The potential predictive value of preoperative brain natriuretic peptide levels in coronary artery bypass grafting surgery. Open Cardiovasc Thorac Surg J 2008;1:27–36. Available at: http://www.benthamscience.com/open/toctsj/articles/V001/27TOCTSJ.pdf. Accessed August 18, 2013.

17.

Song

Kobayashi

Michi

. clinical implication of atrial and brain natriuretic peptide in coronary artery bypass grafting. Asian Cardiovasc Thorac Ann 2004; 12: 41–46.

18.

Masuda

Morita

Tomita

. Off-pump CABG attenuates myocardial enzyme leakage but not postoperative brain natriuretic peptide secretion. Ann Thorac Cardiovasc Surg 2002; 8: 139–144.

19.

Attaran

Sherwood

Desai

. Brain natriuretic peptide a predictive marker in cardiac surgery. Interact Cardiovasc Thorac Surg 2009; 9: 662–666.

20.

Fox

Shernan

Collard

. Preoperative B-type natriuretic peptide is an independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. J Thorac Cardiovasc Surg 2008; 136: 452–461.